BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30183716)

  • 1. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
    Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
    PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes.
    Jin J; Robeson H; Fagan P; Orloff MS
    PLoS One; 2020; 15(12):e0243509. PubMed ID: 33284833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Ramezani S; Sharafshah A; Mirzanejad L; Hadavi M
    Gene; 2019 Sep; 712():143954. PubMed ID: 31288058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
    Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
    J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study.
    Khan AU; Mahjabeen I; Malik MA; Hussain MZ; Khan S; Kayani MA
    PLoS One; 2019; 14(10):e0223882. PubMed ID: 31609976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of haplotype and linkage disequilibrium of PARP1 polymorphisms rs1136410, rs1805405 and rs3219088 with gallbladder cancer.
    Anjali K; Kumar T; Kar AG; Kumar P; Narayan G; Singh S
    Dig Liver Dis; 2023 Jun; 55(6):807-814. PubMed ID: 36581511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2.
    Kim J; Pyun JA; Cho SW; Lee K; Kwack K
    DNA Cell Biol; 2011 Dec; 30(12):1011-7. PubMed ID: 21612407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.
    Sarwar R; Mahjabeen I; Bashir K; Saeed S; Kayani MA
    Cell Physiol Biochem; 2017; 42(1):22-33. PubMed ID: 28490032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PSCA, TNF-α, PARP1 and TP53 Gene Polymorphisms and Gastric Cancer Susceptibility in the Brazilian Population.
    Dantas RN; Souza AM; Herrero SST; Kassab P; Malheiros CA; Lima EM
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):43-48. PubMed ID: 31983162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP1 rs1136410 C/C genotype associated with an increased risk of esophageal cancer in smokers.
    Zhou R; Li Y; Wang N; Niu C; Huang X; Cao S; Huo X
    Mol Biol Rep; 2021 Feb; 48(2):1485-1491. PubMed ID: 33528729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C allele of a synonymous SNP (rs1805414, Ala284Ala) in PARP1 is a risk factor for susceptibility to breast cancer in Saudi patients.
    Alanazi M; Pathan AA; Shaik JP; Amri AA; Parine NR
    Asian Pac J Cancer Prev; 2013; 14(5):3051-6. PubMed ID: 23803078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene-disease association study of IL18 in thyroid cancer: genotype and haplotype analyses.
    Abdolahi F; Dabbaghmanesh MH; Haghshenas MR; Ghaderi A; Erfani N
    Endocrine; 2015 Dec; 50(3):698-707. PubMed ID: 26041375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in base excision repair genes and thyroid cancer risk.
    Santos LS; Branco SC; Silva SN; Azevedo AP; Gil OM; Manita I; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2012 Nov; 28(5):1859-68. PubMed ID: 22922830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of T2285C polymorphism in PARP1 gene coding region with its expression, activity and NSCLC risk along with prognosis.
    Wang Y; Xia XB; Tang HZ; Cai JR; Shi XK; Ji HX; Yan XN; Xu T
    Mutagenesis; 2021 Aug; 36(4):281-293. PubMed ID: 34132814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer.
    Li H; Zha Y; Du F; Liu J; Li X; Zhao X
    J Cell Mol Med; 2020 Dec; 24(24):14639-14644. PubMed ID: 33108038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China.
    Zhou RM; Li Y; Wang N; Niu CX; Huang X; Cao SR; Huo XR
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):2987-2992. PubMed ID: 33112558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients.
    Nogueira A; Assis J; Faustino I; Pereira D; Catarino R; Medeiros R
    Biomarkers; 2017 Feb; 22(1):70-76. PubMed ID: 27323894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1.
    Yosunkaya E; Kucukyuruk B; Onaran I; Gurel CB; Uzan M; Kanigur-Sultuybek G
    Br J Neurosurg; 2010 Oct; 24(5):561-5. PubMed ID: 20868244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.
    Dehghan R; Hosseinpour Feizi MA; Pouladi N; Babaei E; Montazeri V; Fakhrjoo A; Sedaei A; Azarfam P; Nemati M
    Pathol Oncol Res; 2015 Apr; 21(2):449-54. PubMed ID: 25410025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between PARP1 Single Nucleotide Polymorphism and Brain Tumors.
    Wang H; Zhang K; Qin H; Yang L; Zhang L; Cao Y
    Mol Neurobiol; 2016 May; 53(4):2083-9. PubMed ID: 25911198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.